TFF2 and gastric cancer: Gastric cancer (GC) is diagnosed in approximately one million new patients annually1 and usually occurs in the precancerous stage including atrophic gastritis (AG), spasmolytic polypeptide-expressing metaplasia (SPEM), intestinal metaplasia (IM), and intraepithelial neoplasia2.